MOSAIC NASH

The MOSAIC NASH Forum is an engaging event designed to bring together a diverse array of professionals involved in the clinical trial landscape for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH/MASH). This forum will take place at the Embassy of France in Washington DC, and it is specifically aimed at clinical trialists from the fields of cardiology, endocrinology, and hepatology, as well as industry experts, regulatory authorities, payers, patient representatives, and other stakeholders.

The event highlights the pressing public health issue posed by NASH/MASH, which affects approximately 25-30% of adults and is linked to significant liver-related and extra-hepatic morbidity and mortality.

Attendees of the forum can expect to benefit from a wealth of knowledge shared by leading experts and practitioners who are at the forefront of research and development in metabolic diseases. The MOSAIC NASH Forum fosters an environment for cross-specialty collaboration, enabling participants to engage with innovative ideas and strategies related to clinical trials.

The schedule includes presentations on the latest clinical trial data, treatment advancements, and innovative therapies pertinent to MASH and related therapeutic areas. Importantly, the forum also emphasizes understanding the patient perspective, with opportunities for direct engagement with patient advocates to ensure that the needs of those affected by MASH and associated conditions remain a priority in ongoing research and treatment development.

This unique gathering is expected to deliver insights that will shape the future of clinical trials and therapies in cardiology, endocrinology, and hepatology.